2022
DOI: 10.1080/27706710.2022.2075242
|View full text |Cite
|
Sign up to set email alerts
|

Using deep learning to decode abnormal brain neural activity in MDD from single-trial EEG signals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Classifying ALS on a single-trial basis involves training a machine learning model with multiple samples/trials of a quantifiable objective marker that can efficiently predict a sample/trial as ALS or healthy after proper training. Single-trial detection using machine learning has shown great potential in several neural disorders including major depressive disorder (MDD) ( Liu et al, 2022 ), autism spectrum disorder (ASD) ( Ezabadi and Moradi, 2021 ), post-traumatic stress disorder (PTSD) ( Georgopoulos et al, 2010 ), schizophrenia ( Xu et al, 2013 ), amongst other neurologic disorders ( Aoe et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Classifying ALS on a single-trial basis involves training a machine learning model with multiple samples/trials of a quantifiable objective marker that can efficiently predict a sample/trial as ALS or healthy after proper training. Single-trial detection using machine learning has shown great potential in several neural disorders including major depressive disorder (MDD) ( Liu et al, 2022 ), autism spectrum disorder (ASD) ( Ezabadi and Moradi, 2021 ), post-traumatic stress disorder (PTSD) ( Georgopoulos et al, 2010 ), schizophrenia ( Xu et al, 2013 ), amongst other neurologic disorders ( Aoe et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Classifying ALS on a single-trial basis involves training a machine learning model with multiple samples/trials of a quantifiable objective marker that can efficiently predict a sample/trial as ALS or healthy after proper training. Single-trial detection using machine learning has shown great potential in several neural disorders including major depressive disorder (MDD) (Liu et al, 2022), autism spectrum disorder (ASD) (Ezabadi and Moradi, 2021), post-traumatic stress disorder (PTSD) (Georgopoulos et al, 2010), schizophrenia (Xu et al, 2013), amongst other neurologic disorders (Aoe et al, 2019).…”
Section: Introductionmentioning
confidence: 99%